Date: 11 March 2024

Dears,

In reference to the invitation of the ordinary general assembly meeting set to convene on Thursday 28 March 2024, which amongst its agenda items, is the approval of the nomination of the board members for a new duration, and in accordance with Article (50) of the executive regulations of the EGX listing rules, Edita Food industries S.A.E discloses opening the opportunity for the nomination to the board members.

Every shareholder who would like to apply to the board membership must an application to Edita's management at least three days prior to the meeting date by way of : (i) email to: menna.shamseldin@edita.com.eg or (ii) by hand against a receipt, affixing therewith the following documents:

- Name and expertise of the last five years;

- CV, affixed with copies of supporting documents;

- Declaration that the nominated shareholder abides by the provisions of companies law no. 159 of 1981 and all related laws;

- Securities statement providing for the number of shares owned by said shareholder; and

- A Copy of the identification card for natural persons and/or the commercial register of the juristic persons.

After the company examines said requests, the shareholders will review the requests in the ordinary general meeting to ensure that the contemplated nominees fulfill the conditions and regulations set forth in applicable laws.

Best regards,

Ms. Menna Shams El Din

Chief Investor Relations Officer & Corporate Affairs

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END